These results suggest that suppression of HtrA2/Omi expression promotes hepatic fibrogenesis by modulating mitochondrial ROS generation, and these novel mechanistic insights involving the regulation of mitochondrial homeostasis by HtrA2/Omi may be of importance for developing new therapeutic strategies for hepatic fibrosis. This evidence concerns the gene HTRA2 and Hepatic fibrosis.